Phage display technology can be used for the discovery of antibodies for research,
diagnostic, and therapeutic purposes. In this review, we present and discuss key parameters …

Nanomedicines have significant potential for cancer treatment. Although the majority of
nanomedicines currently tested in clinical trials utilize simple, biocompatible liposome …

Peptides are at the cutting edge of contemporary research for new potent, selective, and
safe therapeutical agents. Their rise has reshaped the pharmaceutical landscape, providing …

The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …

The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the
resulting ability to generate monoclonal antibodies (mAbs) initiated a new era in antibody …

Prohibitins (PHBs) are scaffold proteins that modulate many signaling pathways controlling
cell survival, metabolism, and inflammation. Several drugs that target PHBs have been …

Biosensors have been explored for their excellent potential in the field of biological detection
and their application in biomedical diagnosis and have become a rapidly emerging subject …

Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global
imperative. Rapid immunization of the entire human population against a widespread …

The early detection of the onset of transplant rejection is critical for the long-term survival of
patients. The diagnostic gold standard for detecting transplant rejection involves a core …

Phage display involves the expression of selected proteins on the surface of filamentous
phage through fusion with phage coat protein, with the genetic sequence packaged within …